NORMAL SITUATION

Biological Manufacturing Services

Company — Normal situation.

Financial year 2022 · Closed on 31/12/2022

Net result194,3 k €+471,2 %over 1 year
Gross margin261,2 k €+154,6 %over 1 year
Equity1,1 M €+21,5 %over 1 year

Identity

Source · BCE/KBO

Biological Manufacturing Services is a company registered in Belgium.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0885.826.566
Legal form
Public limited company
Contributed capital
534 200,00 €
Latest accounts
31/12/2022
Signals
ProfitableSolid equityGood liquidityPositive cashflowPositive EBITDA

Financials

Source · NBB, 16 filings

Trend over 16 financial years

20222021202020192018
Income statement
Gross margin261,2 k €102,6 k €59,4 k €75,3 k €–
EBITDA261,2 k €101,7 k €56,7 k €74,4 k €72 k €
Operating result261,2 k €44 k €-5,3 k €19,9 k €-10,8 k €
Net result194,3 k €34 k €-7 k €17,3 k €-6,2 k €
Balance sheet
Equity1,1 M €901,8 k €867,8 k €874,8 k €857,5 k €
Total assets1,2 M €996,2 k €1 M €1,1 M €1,2 M €
Cash1,2 M €743,8 k €761,5 k €744 k €882,3 k €
Debts89,1 k €94,4 k €140,7 k €193,6 k €294,4 k €

Board of directors

Source · NBB, accounts to 31/12/2022

5 active · 37 ended

Active mandates

F&C Consulting

Chairman of the board of directors · since 25 juillet 2022 · until 05 mai 2024 · 0712.532.405

Represented by David Georges

Active
MEL MANAGEMENT

Managing director · since 25 juillet 2022 · until 05 mai 2026 · 0681.994.330

Represented by Michel Lussier

Active
Filippo Petti

Director · since 06 mai 2019 · until 25 juillet 2022

Active
NandaDevi

Director · since 01 octobre 2018 · until 25 juillet 2022 · 0655.760.580

Represented by Philippe Dechamps

Active
Michel Lussier

Director · since 20 avril 2015 · until 05 mai 2022

Active

Ended mandates

Filippo PETTI

Director · since 06 mai 2019 · until 06 mai 2024

Ended
NandaDevi

Director · since 01 octobre 2018 · until 05 mai 2024 · 0655.760.580

Represented by Philippe DECHAMPS

Ended
NandaDevi

Director · since 01 octobre 2018 · until 06 mai 2024 · 0655.760.580

Represented by Philippe Dechamps

Ended
Life Science Strategy Consulting

Managing director · since 22 février 2017 · until 04 mai 2021 · 0544.869.388

Represented by Christian Homsy

Ended

Full financial information

Source · NBB
202220212020201920182017
Type of accountMicro modelAbridged modelAbridged modelAbridged modelFull modelFull model
Start of the financial year01/01/202201/01/202101/01/202001/01/201901/01/201801/01/2017
Closing of the financial year31/12/202231/12/202131/12/202031/12/201931/12/201831/12/2017
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date05/06/202324/05/202215/06/202105/06/202025/06/201929/05/2018
General meeting05/05/202305/05/202205/05/202105/05/202006/05/201907/05/2018
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 16 filings
ModelClosingGeneral meetingFiledLanguageDocument
Micro model31/12/202205/05/202305/06/2023FrenchPDF
Abridged model31/12/202105/05/202224/05/2022FrenchPDF
Abridged model31/12/202005/05/202115/06/2021FrenchPDF
Abridged model31/12/201905/05/202005/06/2020FrenchPDF
Full model31/12/201806/05/201925/06/2019FrenchPDF
Full model31/12/201707/05/201829/05/2018FrenchPDF
Full model31/12/201609/06/201729/06/2017FrenchPDF
Abridged model31/12/201504/05/201629/06/2016FrenchPDF
Abridged model31/12/201404/05/201530/06/2015FrenchPDF
Abridged model31/12/201305/05/201416/07/2014FrenchPDF
Abridged model31/12/201204/05/201304/06/2013FrenchPDF
Abridged model31/12/201104/05/201231/05/2012FrenchPDF
Abridged model31/12/201004/05/201111/05/2011FrenchPDF
Abridged model31/12/200904/05/201031/05/2010FrenchPDF
Abridged model31/12/200804/05/200913/05/2009FrenchPDF
Abridged model31/12/200725/06/200817/04/2009FrenchPDF

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2022

5 active · 37 ended

Active mandates

F&C Consulting

Chairman of the board of directors · since 25 juillet 2022 · until 05 mai 2024 · 0712.532.405

Represented by David Georges

Active
MEL MANAGEMENT

Managing director · since 25 juillet 2022 · until 05 mai 2026 · 0681.994.330

Represented by Michel Lussier

Active
Filippo Petti

Director · since 06 mai 2019 · until 25 juillet 2022

Active
NandaDevi

Director · since 01 octobre 2018 · until 25 juillet 2022 · 0655.760.580

Represented by Philippe Dechamps

Active
Michel Lussier

Director · since 20 avril 2015 · until 05 mai 2022

Active

Ended mandates

Filippo PETTI

Director · since 06 mai 2019 · until 06 mai 2024

Ended
NandaDevi

Director · since 01 octobre 2018 · until 05 mai 2024 · 0655.760.580

Represented by Philippe DECHAMPS

Ended
NandaDevi

Director · since 01 octobre 2018 · until 06 mai 2024 · 0655.760.580

Represented by Philippe Dechamps

Ended
Life Science Strategy Consulting

Managing director · since 22 février 2017 · until 04 mai 2021 · 0544.869.388

Represented by Christian Homsy

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Dissolution01/02/2024
    RUBRIQUE FIN (CESSATION, ANNULATION CESSATION, NULLITE, CONC, REORGANISATION JUDICIAIRE, ETC...)
    PDF
  • Mandates24/11/2023
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates11/08/2022
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates31/05/2022
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates27/04/2021
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates23/05/2019
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates14/12/2018
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates23/10/2018
    DEMISSIONS, NOMINATIONS
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2022
    Annual accounts 2022194,3 k €↑
  2. 2021
    Annual accounts 202134 k €↑
  3. 2020
    Annual accounts 2020-7 k €↓
  4. 2019
    Annual accounts 201917,3 k €↑
  5. 2018
    Annual accounts 2018-6,2 k €↓
  6. 2017
    Annual accounts 201716,2 k €↓
  7. 2016
    Annual accounts 201628,7 k €↓
  8. 2015
    Annual accounts 201555,2 k €↑
  9. 2014
    Annual accounts 201452,7 k €↑
  10. 2013
    Annual accounts 201343 k €↓
  11. 2012
    Annual accounts 201295,6 k €↑
  12. 2011
    Annual accounts 201170,7 k €↑
  13. 2010
    Annual accounts 201069,9 k €↑
  14. 2009
    Annual accounts 2009-67,8 k €↓
  15. 2008
    Annual accounts 2008-11,7 k €↑
  16. 2007
    Annual accounts 2007-23 k €